Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
ESMO Gastrointestinal Oncology|February 6, 2026
Single-cell RNA sequencing via endoscopic ultrasound-guided fine-needle biopsy for pancreatic tumors uncovered an aggressive subclone with a poor prognosisY-Y Su, M-Y Lin, S M Cheng, et al.
Oncology|July 1, 1997
Weekly CAF chemotherapy for advanced breast cancer patientsW S Hwang, C A Hsiung, W S Ko, et al.
Cell Death & Disease|July 6, 2012
Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosisB Delage, P Luong, L Maharaj, et al.
The Spine Journal : Official Journal of the North American Spine Society|April 2, 2013
Surgically treated cervical myelopathy: a functional outcome comparison study between multilevel anterior cervical decompression fusion with instrumentation and posterior laminoplastyChusheng Seng, Benjamin P B Tow, Mashfiqul A Siddiqui, et al.
Nutrients|July 3, 2020
Plant-Dominant Low-Protein Diet for Conservative Management of Chronic Kidney DiseaseKamyar Kalantar-Zadeh, Shivam Joshi, Rebecca Schlueter, et al.
Journal of Gastroenterology and Hepatology|June 15, 2012
Digestive cancer management in Asia: position statements: a report on GI Oncology Summit in 2011Joseph J Y Sung, Enders K W Ng, Jaw-Town Lin, et al.
Seminars in Dialysis|April 20, 2017
Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney DiseaseKamyar Kalantar-Zadeh, Susan T Crowley, Srinivasan Beddhu, et al.
ESMO Open|November 8, 2025
Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine-nab-paclitaxel failure: a propensity score-matched analysisG Trovato, D Rossini, A Guidolin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2017
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOST Yoshino, D Arnold, H Taniguchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2015
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancerJ S Chen, C Hsu, N J Chiang, et al.
Pageof 17